US Patent Issued to RedHill Biopharma on July 29 for "Therapy for inhibition of single-stranded RNA virus replication" (Israeli, American Inventors)

ALEXANDRIA, Va., July 30 -- United States Patent no. 12,370,206, issued on July 29, was assigned to RedHill Biopharma Ltd. (Tel-Aviv, Israel).

"Therapy for inhibition of single-stranded RNA virus replication" was invented by Reza Fathi (Oradell, N.J.), Dror Ben-Asher (Tel-Aviv, Israel) and Guy Goldberg (Tel-Aviv, Israel).

According to the abstract* released by the U.S. Patent & Trademark Office: "Pharmaceutical compositions showing the ability to inhibit or suppress replication of a filovirus in an individual are disclosed. The disclosed compositions are useful for treating, preventing, or reducing the spread of infections by filovirus. A method includes administering at least one agent of the present disclosure to an individual infected ...